Prometric Questions - Yellow File - MOH | SPLE | HAAD | DHA - 34



A 35-year-old individual is receiving 20 mg of propranolol hydro four times daily as a prophylaxis to migraine attacks. The drug has 25% bioavailability due to extensive first pass effect. What amount of the drug reaches the systemic circulation after dosing?
A) 2.5 mg  B) 5.0 mg  C) 7.5 mg  D)10mg

Calculation

Bioavailability (F) = 25% = 0.25

Dose = 20 mg

Amount reaching systemic circulation:

Systemic amount = Dose × Bioavailability

= 20 mg × 0.25
= 5 mg

Correct answer: B) 5.0 mg

Exam tip:
When bioavailability is given as a percentage, multiply the dose by that fraction.
25% of 20 mg = 5 mg.

Rationale for Incorrect Options

  • A) 2.5 mg: Incorrect calculation (represents 12.5% bioavailability or half of the actual systemic amount).

  • C) 7.5 mg: Incorrect calculation (represents 37.5% bioavailability).

  • D) 10 mg: Incorrect calculation (represents 50% bioavailability).

If a study is to follow a group of smokers and a group of nonsmokers time, and see which ones eventually develops lymphoma and which one doesn't. What do you call this study design?
A) Retrospective cohort study  B) Prospective cohort study  C) Cross-sectional study  D) Case-series   

The correct answer is B) Prospective cohort study.

Clinical & Epidemiological Rationale
Prospective Cohort Study: In this design, participants are selected based on their exposure status (smokers vs. non-smokers) before the outcome occurs. They are then followed forward in time to observe and compare the incidence rate of developing the outcome (lymphoma) in both groups.

Rationale for Incorrect Options

  • A) Retrospective cohort study: Exposure and outcome have already occurred at the start of the study. Researchers look back at historical records (e.g., occupational records from 20 years ago) to classify exposure and then trace outcomes up to the present.

  • C) Cross-sectional study: Evaluates exposure and disease status simultaneously at a single point in time ("snapshot"). It measures prevalence rather than incidence and cannot prove temporal relationship or sequence (which came first).

  • D) Case-series: An observational, descriptive study tracking a small group of patients with a known condition or outcome (e.g., 10 patients with lymphoma) without a non-exposed control group.

A 74-year-old man with chest infection is admitted to a teaching hospital. The patient requires chest X-ray. The chief resident ordered bronchoscopy to be conducted. One of her reasons for this decision was to allow an inexperienced intern to practice this technical procedure.  Which of the following describes his action? 
A) Individual patients are not obligated to participate in the society's future physicians, but if the patients agree, it is acceptable
B) Good as this is a teaching hospital and the student have these skills to function effectively as physicians 
C) Procedures involving any risk should be performed only for diagnostic or therapeutic purposes but not teaching 
D) The senior physician should remain present when inexperience students make this procedure  

A)Monetary units (e.g. dollars)
B) Quality- adjusted life-years (QALYS)
C) Natural units (e.g. Life-years saved) 
D) Comparing the cost of two identical products (e.g. generic brand)

The correct answer is D) Comparing the cost of two identical products (e.g. generic brand).

Rationale

  • Cost-Minimization Analysis (CMA): In CMA, the health outcomes or efficacy of the interventions being compared are proven or assumed to be identical (equivalent). Because the clinical outcomes are equal, the analysis does not measure different units of health outcomes—it simply compares the costs to find the least expensive alternative (such as comparing a brand-name drug to an identical generic equivalent).

Rationale for Incorrect Options

  • A) Monetary units (e.g. dollars): Applies to Cost-Benefit Analysis (CBA), where both the inputs (costs) and the health outcomes/benefits (e.g., economic productivity gained, life value) are measured in monetary terms ($).

  • B) Quality-adjusted life-years (QALYs): Applies to Cost-Utility Analysis (CUA), where outcomes are measured in utility units that combine both the length and quality of life (QALYs or DALYs).

  • C) Natural units (e.g. Life-years saved): Applies to Cost-Effectiveness Analysis (CEA), where health outcomes are measured in natural clinical units (e.g., mmHg blood pressure reduction, life-years gained, cholesterol points reduced).

Analysis
Outcome measured in
CMA
Equivalent outcomes → compare costs
CEA
Natural units (life-years, mmHg reduction, cases prevented)
CUA
QALYs/DALYs
CBA
Monetary units

Which of the following statements provides the best described incremental cost-effectiveness ratio?
A)The cost per extra benefit of a new strategy, independent 
B) The extra cost to obtain an extra benefit when switching alternative to another 
C) The cost per quality-adjusted life year gained
D) A summary measurement of efficiency  

The correct answer is B) The extra cost to obtain an extra benefit when switching from one alternative to another.

Mathematical & Conceptual Rationale

The Incremental Cost-Effectiveness Ratio (ICER) measures the additional economic cost associated with gaining an additional unit of health benefit when comparing a new treatment or intervention against an existing standard or alternative.

Mathematically, it is expressed as:



Rationale for Incorrect Options
  • A) The cost per extra benefit of a new strategy, independent (Incorrect): Cost-effectiveness and incremental ratios are fundamentally comparative—they can never be evaluated independently in a vacuum without comparing against an existing alternative or standard of care.

  • C) The cost per quality-adjusted life year gained (Incorrect): This specifically defines the outcome measure used in a Cost-Utility Analysis (CUA). While an ICER can be calculated in terms of cost per QALY gained, this definition is too narrow because ICERs can also measure natural health units (e.g., cost per life-year saved, cost per stroke prevented, cost per mmHg blood pressure reduction).

  • D) A summary measurement of efficiency (Incorrect): This is a generic description applicable broadly to various pharmacoeconomic metrics (such as the average Cost-Effectiveness Ratio or Net Monetary Benefit), but it fails to define the incremental component of the ICER.

Which of the following governmental bodies is responsible for diseases prevention during Hajj?  A) Ministry of Health  B) Saudi Health Council  C) Saudi Food and drug authority  D) Saudi commission for Health specialists

The correct answer is A) Ministry of Health.

Roles & Responsibilities

  • Ministry of Health (MOH): Responsible for public health promotion, preventive medicine, epidemiological surveillance, quarantine management, and infectious disease control during the Hajj season. The MOH publishes annual health requirements/vaccination guidelines for pilgrims and operates specialized health facilities at holy sites.

Rationale for Other Options

  • B) Saudi Health Council: Sets overall strategic health policies, regulations, and coordination frameworks among Saudi healthcare sectors, but does not directly execute operational disease prevention or clinical management on the ground.

  • C) Saudi Food and Drug Authority (SFDA): Regulates and ensures the safety of food, human/veterinary drugs, biological products, and medical devices across the Kingdom.

  • D) Saudi Commission for Health Specialties (SCFHS): Oversees the accreditation, classification, training, and licensing of healthcare practitioners (doctors, pharmacists, nurses).


What is the description of viruses that live as parasites on bacteria?
A) Fungi  B) Lichens  
C) Commensals  D)Bacteriophage 

The correct answer is D) Bacteriophage.

Microscopic & Microbiological Rationale

  • Bacteriophages (or phages): Viruses that specifically infect, replicate within, and destroy bacteria. They attach to bacterial cell walls, inject their genetic material (DNA or RNA), and hijack the host bacterium's cellular machinery to replicate, operating as obligate intracellular parasites of bacteria.

Rationale for Incorrect Options

  • A) Fungi: Eukaryotic organisms (such as yeasts, molds, and mushrooms) that are distinct from viruses and bacteria. They absorb nutrients from their environment rather than living as viral parasites on bacteria.

  • B) Lichens: Complex symbiotic organisms formed by a mutualistic relationship between a fungus and a photosynthetic partner (an alga or a cyanobacterium), not viruses.

  • C) Commensals: Organisms that live on or inside a host body in a relationship (commensalism) where one organism benefits and the other is neither harmed nor benefited. This describes a lifestyle/ecological interaction, not a type of virus.

To read more such exam questions with explanation visit the blog or click on Prometric Exams

Post a Comment

0 Comments

Contact

Name

Email *

Message *